In Response to Current Global Supply Disruption

Ed Hamdeh • May 13, 2022

kbDNA has ready-to-ship products in North America

Disruptions in Asia are weighing on the global supply chain. In the U.S, the effects can be felt all across research laboratories, especially in bioscience sectors. Whether it's equipment, consumables or specialty reagents; everyone seems to be waiting on overdue products and ambiguous delivery dates.

 

As domestic providers, we offer more flexibility to help resolve immediate laboratory needs. Contact us at kbDNA for general product inquiries.

Products Include:

If you are experiencing order delays...

Send us a brief description of your product needs. We will get back to you with pricing & lead time!

Ask us

By Ed Hamdeh April 17, 2026
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
By Laith Khalil March 9, 2026
AI promises to transform biotech, but real-world results are more incremental. A practical perspective on AI in drug discovery, genomics, diagnostics, and lab automation.
October 23, 2025
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.